Top Stories
Suzlon Energy Q4 results: Revenue jumps 45%, EBITDA rises 39% YoY Crude down 5.45% on MCX but gold and silver barely moved — the USDINR effect explained Petrol crosses ₹100 in Delhi for first time as 4th fuel hike in 12 days adds ₹2.61 per litre Hindalco Industries Q4 Results: EBITDA crosses ₹10,000 crore; revenue jumps 20% YoY RBI to transfer record Rs 2.87 lakh crore dividend to government for FY26; balance sheet expands 20.61% Sun Pharma Q4 Results: Net profit rises 26.2% YoY, EBITDA grows over 6% Info Edge Q4 results: Revenue up 17%, operating margins improve 639 bps YoY Supreme Court to hear PIL against CBSE’s compulsory third language rule for Class 9 students next week Suzlon Energy Q4 results: Revenue jumps 45%, EBITDA rises 39% YoY Crude down 5.45% on MCX but gold and silver barely moved — the USDINR effect explained Petrol crosses ₹100 in Delhi for first time as 4th fuel hike in 12 days adds ₹2.61 per litre Hindalco Industries Q4 Results: EBITDA crosses ₹10,000 crore; revenue jumps 20% YoY RBI to transfer record Rs 2.87 lakh crore dividend to government for FY26; balance sheet expands 20.61% Sun Pharma Q4 Results: Net profit rises 26.2% YoY, EBITDA grows over 6% Info Edge Q4 results: Revenue up 17%, operating margins improve 639 bps YoY Supreme Court to hear PIL against CBSE’s compulsory third language rule for Class 9 students next week

Mankind Pharma Share Price

Mankind Pharma (NSE: MANKIND) — live NSE quote, intraday chart, 52-week range, peers and latest news.

Healthcare

₹2,457.50
▼ -21.90 (-0.88%)
Intraday -21.90 (-0.88%)
09:15 Prev Close ₹2,479.40 15:30
Open 2,508.60
High 2,510.00
Low 2,439.70
Prev Close 2,479.40
Volume 6.46 L
52-Week High 2,716.50
52-Week Low 1,909.70
Updated: May 25, 2026, 04:46 PM IST
52-Week Range 9.53% below high · 28.69% above low
₹2,457.50
Low ₹1,909.70 High ₹2,716.50

Latest News on Mankind Pharma

View all Mankind Pharma news →